3-38566531-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PP2PP3_Moderate
The NM_000335.5(SCN5A):āc.3715G>Cā(p.Glu1239Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000297 in 1,614,010 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000335.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN5A | NM_001099404.2 | c.3718G>C | p.Glu1240Gln | missense_variant | Exon 21 of 28 | ENST00000413689.6 | NP_001092874.1 | |
SCN5A | NM_000335.5 | c.3715G>C | p.Glu1239Gln | missense_variant | Exon 21 of 28 | ENST00000423572.7 | NP_000326.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN5A | ENST00000413689.6 | c.3718G>C | p.Glu1240Gln | missense_variant | Exon 21 of 28 | 5 | NM_001099404.2 | ENSP00000410257.1 | ||
SCN5A | ENST00000423572.7 | c.3715G>C | p.Glu1239Gln | missense_variant | Exon 21 of 28 | 1 | NM_000335.5 | ENSP00000398266.2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152224Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251026Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135772
GnomAD4 exome AF: 0.0000308 AC: 45AN: 1461786Hom.: 0 Cov.: 31 AF XY: 0.0000234 AC XY: 17AN XY: 727200
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152224Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74358
ClinVar
Submissions by phenotype
not provided Uncertain:2
This sequence change replaces glutamic acid, which is acidic and polar, with glutamine, which is neutral and polar, at codon 1240 of the SCN5A protein (p.Glu1240Gln). This variant is present in population databases (rs199473211, gnomAD 0.007%). This missense change has been observed in individuals with Brugada syndrome and/or SCN5A-related conditions (PMID: 11901046, 30203441, 37937776). This variant is also known as c.3715G>C, p.Glu1239Gln. ClinVar contains an entry for this variant (Variation ID: 67818). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
Cardiac arrhythmia Uncertain:2
This missense variant replaces glutamic acid with glutamine at codon 1240 of the SCN5A protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). A functional study has shown that this variant does not affect the channel function (PMID: 30891416). This variant has been reported in an individual affected with Brugada syndrome (PMID: 11901046). This variant has aslo been reported in an individual affected with unexplained sudden cardiac arrest and recurrent ventricular tachycardia and ventricular fibrillation episodes (PMID: 30891416). However, no Brugada ECG pattern was observed in this individual or five other asymptomatic family member carriers. This variant has also been identified in 10/251026 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
This missense variant replaces glutamic acid with glutamine at codon 1240 of the SCN5A protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). Functional studies have shown this variant does not affect the channel function (PMID: 30891416). This variant has been reported in an individual affected with Brugada syndrome (PMID: 11901046). This variant has been reported in an individual affected with unexplained sudden cardiac arrest and recurrent ventricular tachycardia and ventricular fibrillation episodes (PMID: 30891416). However, no Brugada ECG pattern was observed in this individual or five other asymptomatic family member carriers. This variant has also been identified in 10/251026 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
not specified Pathogenic:1
- -
SUDDEN INFANT DEATH SYNDROME;C1832680:Dilated cardiomyopathy 1E;C1837845:Sick sinus syndrome 1;C1859062:Long QT syndrome 3;C1879286:Progressive familial heart block, type 1A;C2751898:Ventricular fibrillation, paroxysmal familial, type 1;C3151464:Atrial fibrillation, familial, 10;C4551804:Brugada syndrome 1 Uncertain:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Brugada syndrome Other:1
This variant has been reported as associated with Brugada syndrome in the following publications (PMID:11901046). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at